What to know about ACIP's vote on hepatitis B vaccine - Summary - MDSpire

What to know about ACIP's vote on hepatitis B vaccine

  • By

  • Laura Ungar

  • Mike Stobbe

  • December 3, 2025

  • 0 min

Share

Objective:

To summarize the recent changes in hepatitis B vaccination guidelines by the ACIP and the implications of these changes.

Key Findings:
  • Hepatitis B can lead to chronic infections, liver failure, and cancer, especially in infants.
  • The ACIP's new recommendation allows parents to decide on vaccination timing, which could lead to increased infections.
  • Delaying the vaccine could result in an estimated 1,400 additional infections and 480 deaths among children.
Interpretation:

The ACIP's decision may undermine decades of public health success in reducing hepatitis B infections among children.

Limitations:
  • The report estimating potential infections and deaths has not yet been peer-reviewed.
  • State and local health officials may not follow the new guidelines, leading to inconsistencies in vaccination practices.
Conclusion:

The ACIP's decision has sparked significant concern among health professionals, who fear it could reverse progress in hepatitis B prevention.

Original Source(s)

Related Content